Cardiometabolic Health Congress (CMHC) | VuMedi

Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress (CMHC)

The global epidemic of metabolic syndrome, a constellation of cardiometabolic risk factors, and that of obesity, type 2 diabetes, atherosclerosis, chronic kidney disease, cardiovascular disease, and NAFLD/NASH, have become the modern-day health hazard across the world. Lifestyle factors, including a lack of physical activity and proper nutrition, as well as ...
read more ↘ smoking, can further exacerbate the impacts of cardiometabolic risk or disease, which is showing no signs of slowing down. Overall, the numbers are particularly striking. There are more than 463 million adults living with diabetes worldwide, and the number is expected to rise to more than 700 million by 2045.1 Furthermore, 232 million have undiagnosed diabetes with an additional 374 million having prediabetes.1 The increasing prevalence of overweight and obesity (now estimated to affect 2 billion adults, or nearly 30% of the world population), high cholesterol (>40% of the world’s population), and hypertension (>1 billion), together with type 2 diabetes (T2D), are some of the major drivers of morbidity and mortality worldwide.2-4 They affect multiple organ systems, including the heart, liver, and kidneys, spanning several disease domains and outcomes.

Although clinicians are learning more about the interconnections between these conditions and risk factors, the application of these principles to patient care remains in its infancy. As these diseases and risk factors exist in a continuum, they cannot be treated in silos, which is unfortunately what tends to happen in clinical practice. The Cardiometabolic Health Congress (CMHC) has been at the forefront of looking at the whole spectrum of cardiometabolic disease, including obesity, diabetes, lipids, hypertension, cardio-renal disease, and practical ways to address them. Through our live conferences and extensive online education platforms, we strive to synthesize and translate the latest cutting-edge medical research into practical clinical strategies for preventing, delaying, diagnosing, treating, and managing the whole spectrum of cardiometabolic disorders. The goal is to provide the medical community with evidence-based interventions that they can apply immediately in clinical practice to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.
↖ read less

2020 Annual CMHC Symposia

Cardiometabolic Health Congress (CMHC)

Postprandial Glucose Control: What Are the Different Types of New CGMs, and Standardized CGM Metrics and Reporting Guidelines?

FEATURING Athena Philis-Tsimikas

27 views
February 9, 2021

Cardiometabolic Health Congress (CMHC)

Postprandial Glucose Control: How To Identify and Treat Postprandial Hyperglycemia, and Avoid Insulin Overbasalization?

FEATURING Athena Philis-Tsimikas

711 views
February 9, 2021
3

Cardiometabolic Health Congress (CMHC)

Hyperkalemia in the Cardiometabolic Patient: What Are the Stages of Treatment? How Should We Approach HF Patients? Should We Worry About Mild Hyperkalemia?

FEATURING Javed Butler

94 views
January 28, 2021

Cardiometabolic Health Congress (CMHC)

Hyperkalemia in HF Patients: Are Sodium Zirconium Cyclosilicate and Patiromer Safe and Effective in Managing Hyperkalemia While Continuing Your HF Treatment?

FEATURING Javed Butler

258 views
January 28, 2021

Cardiometabolic Health Congress (CMHC)

Metabolic Surgery for Diabetes & CV Disease: Is There a Benefits for Patients Outside NIH Criteria?

FEATURING David Cummings

359 views
January 5, 2021
3

Cardiometabolic Health Congress (CMHC)

What Is the Link Between Diabetes, CAD, and CVD?

FEATURING Deepak Bhatt

94 views
December 28, 2020

Cardiometabolic Health Congress (CMHC)

Prevention of Cardiovascular Events in High-Risk Diabetes Patients With CAD: What Is the Efficacy of Ticagrelor With Aspirin?

FEATURING P. Gabriel Steg

226 views
December 28, 2020

Cardiometabolic Health Congress (CMHC)

78 y/o Female, Nonsmoker With T2DM, Hypercholesterolemia, Hypertension, and Epigastric Distress: How to Select Antihyperglycemic Agents, and What Are the Strategies for CV Risk Prevention?

FEATURING Lawrence Leiter

65 views
December 28, 2020

Cardiometabolic Health Congress (CMHC)

Preventing Cardiovascular Events in High-Risk Diabetes Patients with CAD: New Insights and Developments, Panel Discussion

FEATURING Deepak Bhatt, P. Gabriel Steg, Lawrence Leiter

110 views
December 28, 2020

Cardiometabolic Health Congress (CMHC)

What Are the Current Trends of CKD in T2D?

FEATURING George Bakris

435 views
December 28, 2020
5

Cardiometabolic Health Congress (CMHC)

Diabetic Kidney Disease ADA Guidelines for Early Recognition & Screening

FEATURING Janet Mcgill

477 views
December 28, 2020
4

Cardiometabolic Health Congress (CMHC)

Diabetic Kidney Disease Management: What Are the Strategies to Slow the Progression, and Effect of Finerenone on CKD Outcomes?

FEATURING Rajiv Agarwal

766 views
December 28, 2020
6

Cardiometabolic Health Congress (CMHC)

63 y/o Male With BP 162/86 mmHg, 84 bpm Heart Rate, Dyspnea, PMH-Hypertension, and T2D: What Would Be the Next Steps in Managing Risk Factors?

FEATURING Rajiv Agarwal, Janet Mcgill

110 views
December 28, 2020
1

Cardiometabolic Health Congress (CMHC)

59 y/o Male With Hypertension, Diabetes, CKD, Obesity, and Hypercholesterolemia: What Would Be an Optimal Consideration for the Clinical Care?

FEATURING Ileana Pina, Javed Butler, Matthew Weir

304 views
December 21, 2020
3

Cardiometabolic Health Congress (CMHC)

Insights From the COMPASS Trial: Management of PAD in Patients With Cardiometabolic Disease

FEATURING Deepak Bhatt

151 views
December 18, 2020

Cardiometabolic Health Congress (CMHC)

PAD treatment for Patients With ALI, Polyvascular and Cardiometabolic Disease: How Effective Are Vorapaxar, Ticagrelor and Rivaroxaban?

FEATURING Marc Bonaca

114 views
December 18, 2020

Cardiometabolic Health Congress (CMHC)

69 y/o Woman With LHC for NSTEMI & 76 y/o Woman With Life-Limiting Claudication: What Is the Optimal Management Strategy?

FEATURING Manesh Patel

7 views
December 18, 2020

Cardiometabolic Health Congress (CMHC)

Panel Discussion on Preventing Adverse Cardiovascular and Limb Events in Cardiometabolic Patients with PAD: Recent Trials and Advances

FEATURING Deepak Bhatt, Marc Bonaca, Manesh Patel

39 views
December 18, 2020

Cardiometabolic Health Congress (CMHC)

Postprandial Glucose Control & Advancing Insulin Therapy: How to Identify and Treat Postprandial Hyperglycemia, and Avoid Insulin Overbasalization?

FEATURING Athena Philis-Tsimikas

22 views
December 18, 2020

Cardiometabolic Health Congress (CMHC)

CMHC Update on Postprandial Glucose Control: How Can CGM Help Us to Target PPG?

FEATURING Irl Hirsch

125 views
December 18, 2020
1

Cardiometabolic Health Congress (CMHC)

2020 CMHC Update on Hyperkalemia in Cardiometabolic Patients: What Are the Causes & When Is the Right Time to Use Precision Medicine?

FEATURING Ileana Pina

62 views
December 18, 2020
1

Cardiometabolic Health Congress (CMHC)

Hyperkalemia in Cardiometabolic Patients: What Is the Importance of RAASi Therapy for HF and CKD? Are SGLT2 Inhibitors Promising Additional Therapy?

FEATURING Ileana Pina

180 views
December 18, 2020
1

Cardiometabolic Health Congress (CMHC)

Hyperkalemia: What Is It & What Are the Important Comorbidities?

FEATURING Javed Butler

225 views
December 18, 2020

Cardiometabolic Health Congress (CMHC)

What Are the New Treatment Options for Hyperkalemia in Cardiometabolic Patients?

FEATURING Javed Butler

15 views
December 18, 2020